Skip to content

Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-Rater Reliability of Common Terminology Criteria for Adverse Event Ratings

Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-Rater Reliability of Common Terminology Criteria for Adverse Event Ratings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04066868
Enrollment
1013
Registered
2019-08-26
Start date
2020-02-10
Completion date
2024-12-06
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

patient-reported outcomes (PRO), common terminology criteria for adverse events (CTCAE), quality of life, electronic data assessment

Brief summary

This open randomized trial investigates, if clinicians complete CTCAE ratings differently when receiving patients' patient-reported outcome (PRO) data prior to their CTCAE completion. The primary objective is to demonstrate superior inter-rater reliability of CTCAE ratings from physicians relying on EORTC PRO data as additional data source over traditional CTCAE ratings not including PRO information.

Detailed description

In oncology, detection and tracking of adverse events (AEs) are a top priority in both clinical trials and routine care. The classification of AEs mostly relies on the Common Toxicity Terminology for Adverse Events (CTCAE) developed by the US-American National Institutes of Health and the National Cancer Institute. It is known, however, that the assessment of AEs can greatly vary depending on whether they are assessed by patients or by clinicians. Procedure: The patients (any oncological diagnosis, day clinic or inpatient for treatment with chemotherapy or immunotherapy; open 1:1 randomized) fill out an EORTC quality of life questionnaire electronically (C30 + further questions). These PRO data are immediately available for the clinicians. Independently of each other, two different clinicians conduct a medical consultation with the patient and electronically a CTCAE rating. For the intervention Group, clinicians see the PRO values directly next to the input options for the CTCAE rating. For the control Group, clinicians see the input options for the CTCAE rating. The similarity of the assessments is checked using intra-class correlation. The combined use of PROs and CTCAE data makes particular sense for AEs/aspects that are directly experienced by the patient (fatigue, pain, cognitive problems, emotional functioning, ...) and can only be adequately recorded by the clinician through communication with the patient.

Interventions

OTHERPatient-reported outcomes assessment

Patient-reported outcomes are electronically assessed using EORTC QOL measures

OTHERCTCAE rating

CTCAE Ratings are conducted by clinicians

OTHERPRO data is displayed

PRO data is displayed right next to the CTCAE rating

Sponsors

Bezirkskrankenhaus Kufstein
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Besancon
CollaboratorOTHER
Martin-Luther-Universität Halle-Wittenberg
CollaboratorOTHER
Università di Cagliari
CollaboratorUNKNOWN
Kansai Medical University
CollaboratorOTHER
King Hussein Cancer Center
CollaboratorOTHER
Tata Memorial Hospital
CollaboratorOTHER_GOV
Rigshospitalet, Denmark
CollaboratorOTHER
Clinical Hospital Center Rijeka
CollaboratorOTHER
N.N. Blokhin National Medical Research Center of Oncology
CollaboratorOTHER
Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* any Cancer diagnosis * current treatment with chemotherapy or immunotherapy * symptom burden equal or greater score 3 of the screening question On a scale of 0 to 10, to what degree did you experience physical or emotional symptoms/problems during the last week? * ability to understand the questions linguistically and cognitively * written informed consent Exclusion Criterion: * psychiatric diagnosis or mental health problems

Design outcomes

Primary

MeasureTime frameDescription
EORTC Quality of Life Questionnaire C30 and additional questions from the EORTC Item Librarysingle assessment of quality of life before the medical consultationpatient-reported quality of life
CTCAE V5.0single assessment during the medical consultation with physician 1 on the same day of PRO assessmentphysician 1 rates patient symptoms (17 CTCAE domains matching the EORTC C30 and additional questions)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026